Glycogen Storage Disease Type V
Glycogen storage disease type V (GSD-V) is a metabolic disorder, more specifically a glycogen storage disease, caused by a deficiency of myophosphorylase. Its incidence is reported as 1 in 100,000, approximately the same as glycogen storage disease type I.
GSD type V is also known as McArdle disease or muscle phosphorylase (myophosphorylase) deficiency. The disease was first reported in 1951 by Dr. Brian McArdle of Guy's Hospital, London.
Read more about Glycogen Storage Disease Type V: History, Symptoms and Presentation, Laboratory Tests, Treatment/Therapy, Genetic Basis, The Reaction
Famous quotes containing the words storage, disease and/or type:
“Many of our houses, both public and private, with their almost innumerable apartments, their huge halls and their cellars for the storage of wines and other munitions of peace, appear to me extravagantly large for their inhabitants. They are so vast and magnificent that the latter seem to be only vermin which infest them.”
—Henry David Thoreau (1817–1862)
“Health is a state of complete physical, mental and social well-being, and not merely the absence of disease or infirmity.”
—Constitution of the World Health Organization.
“To put it rather bluntly, I am not the type who wants to go back to the land; I am the type who wants to go back to the hotel.”
—Fran Lebowitz (b. 1951)